Cargando…
A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines
PURPOSE: Irinotecan (CPT-11) and SN-38 – its active metabolite – are alkaloid-derived topoisomerase I interactive compounds widely used in various cancer therapy protocols. To solve the problems associated with the instability of their lactone ring at physiological pH and with the extreme insolubili...
Autores principales: | Casadó, Ana, Sagristá, M Lluïsa, Mora, Margarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141119/ https://www.ncbi.nlm.nih.gov/pubmed/30254436 http://dx.doi.org/10.2147/IJN.S166219 |
Ejemplares similares
-
Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study
por: Wu, Chan, et al.
Publicado: (2018) -
Formulation of Piperine–Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation
por: Imam, Syed Sarim, et al.
Publicado: (2021) -
Evaluation of the In Vitro Cytotoxic Activity of Caffeic Acid Derivatives and Liposomal Formulation against Pancreatic Cancer Cell Lines
por: Zaremba-Czogalla, Magdalena, et al.
Publicado: (2020) -
Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017) -
Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer
por: Shah, Vidhi M., et al.
Publicado: (2022)